Literature DB >> 18030551

[Diagnosing fungal infections: trends and new developments].

Birgit Willinger1.   

Abstract

Diagnosing fungal infections remains a problem, particularly in the immunocompromised patient. Symptoms are mostly non-specific and colonization is difficult to distinguish from invasive disease. Existing diagnostic tools often lack sensitivity. Thus, the combination of various diagnostic tools is mandatory to allow earlier diagnosis of systemic fungal infections. Microscopy, culture based methods, antigen detection and molecular techniques such as PCR may help to facilitate and accelerate the diagnosis. Sensitive and specific PCR assays to detect fungal DNA are an important part of the diagnostic approach. But extensive validation and standardization is strongly needed before PCR assays can be used in a routine laboratory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030551     DOI: 10.1007/s10354-007-0462-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  24 in total

Review 1.  British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Authors:  David W Denning; Christopher C Kibbler; Rosemary A Barnes
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

2.  Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata.

Authors:  Birgit Willinger; Susanne Wein; Alexander M Hirschl; Manfred L Rotter; Mammad Manafi
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 3.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens.

Authors:  Claudia Schabereiter-Gurtner; Brigitte Selitsch; Manfred L Rotter; Alexander M Hirschl; Birgit Willinger
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

5.  Rapid microscopical diagnosis of deep-seated mycoses following maceration of fresh specimens and staining with optical brighteners.

Authors:  R Rüchel; S Margraf
Journal:  Mycoses       Date:  1993 Jul-Aug       Impact factor: 4.377

6.  Comparison of aerobic standard medium with specific fungal medium for detecting fusarium spp in blood cultures.

Authors:  C Hennequin; C Ranaivoarimalala; T Chouaki; M Tazerout; T Ancelle; J J Cabaud; C P Raccurt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-10-02       Impact factor: 3.267

7.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue.

Authors:  R Bialek; F Konrad; J Kern; C Aepinus; L Cecenas; G M Gonzalez; G Just-Nübling; B Willinger; E Presterl; C Lass-Flörl; V Rickerts
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

8.  Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures.

Authors:  D A Wilson; M J Joyce; L S Hall; L B Reller; G D Roberts; G S Hall; B D Alexander; G W Procop
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

9.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.

Authors:  Barbara D Alexander; Elizabeth Dodds Ashley; L Barth Reller; Shelby D Reed
Journal:  Diagn Microbiol Infect Dis       Date:  2006-02-08       Impact factor: 2.803

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.